Inogen | INGN - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Abbott USD 16.5B 1.91B 2025-12
Accuray USD 194.61M 2.03M 2025-09
AngioDynamics USD 71.96M 3.68M 2025-09
Artivion USD 101.56M 15.72M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Chart Industries USD 2.13B 90.4M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.59B 183.3M 2025-09
Globus Medical USD 498.5M 32.54M 2025-12
Inogen USD 64.94M 2.12M 2025-09
Insulet USD 680.1M 32.4M 2025-12
Masimo USD 371.6M 1.9M 2025-12
Medtronic USD 9.5B 440M 2025-12
Orthofix International USD 170.48M 10.64M 2025-12
Philips EUR 7.51B 479M 2025-12
ResMed USD 1.25B 7.39M 2025-12
Steris USD 922.3M 33.4M 2025-12
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
X T L Biopharmaceuticals USD 761K 1.45M 2025-06
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12